Arrowhead Pharmaceuticals Inc. buy HC Wainwright
Start price
08.02.24
/
50%
€28.61
Target price
08.02.25
€83.48
Performance (%)
-26.04%
Price
31.05.24
€21.16
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.04%. This prediction currently runs until 08.02.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -7.759% | -7.759% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by HC_Wainwright for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by HC_Wainwright for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.12
13.05.24
13.05.24
€83.32
13.05.25
13.05.25
5.17%
31.05.24
31.05.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.39
10.08.23
10.08.23
€81.59
10.08.24
10.08.24
-19.82%
31.05.24
31.05.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.89
13.07.23
13.07.23
€80.49
13.07.24
13.07.24
-32.41%
31.05.24
31.05.24